Current and Emerging Options for the Management of Inherited von Willebrand Disease

por Heijdra, Jessica M., Cnossen, Marjon H., Leebeek, Frank W. G.
Publicado 2017

Impact of extreme weight loss on factor VIII concentrate pharmacokinetics in haemophilia

por van Moort, Iris, Bukkems, Laura H, Nieuwenhuizen, Laurens, Cnossen, Marjon H
Publicado 2021

Patient-relevant health outcomes for von Willebrand disease, platelet function disorders, and rare bleeding disorders: a Delphi study

por van Hoorn, Evelien S., Lingsma, Hester F., Cnossen, Marjon H., Gouw, Samantha C.
Publicado 2023

Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis

por Boeddha, Navin P., Driessen, Gertjan J., Cnossen, Marjon H., Hazelzet, Jan A., Emonts, Marieke
Publicado 2016

Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis

por Bukkems, Laura H., Jönsson, Siv, Cnossen, Marjon H., Karlsson, Mats O., Mathôt, Ron A. A.
Publicado 2023

Limited sampling strategies for individualized BAX 855 prophylaxis in severe hemophilia A: in silico evaluation

por Bukkems, Laura H., Goedhart, Tine M.H.J., Zwaan, C. Michel, Cnossen, Marjon H., Mathôt, Ron A.A.
Publicado 2023

A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol

por Madderom, Marlous J., Heijdra, Jessica, Utens, Elisabeth M. W. J., Polinder, Suzanne, Rijneveld, Anita W., Cnossen, Marjon H.
Publicado 2016

Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice

por Goedhart, Tine M. H. J., Bukkems, Laura H., Zwaan, C. Michel, Mathôt, Ron A. A., Cnossen, Marjon H.
Publicado 2021

Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A

por Bukkems, Laura H., Versloot, Olav, Cnossen, Marjon H., Jönsson, Siv, Karlsson, Mats O., Mathôt, Ron A.A., Fischer, Kathelijn
Publicado 2022

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding

por Atiq, Ferdows, Wuijster, Esmee, de Maat, Moniek P.M., Kruip, Marieke J.H.A., Cnossen, Marjon H., Leebeek, Frank W.G.
Publicado 2021

Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals’ views

por Houwing, Maite E., Buddenbaum, Marit, Verheul, Thijs C. J., de Pagter, Anne P. J., Philipsen, Jacobus N. J., Hazelzet, Jan A., Cnossen, Marjon H.
Publicado 2021

DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing o...

por Donners, Anouk, van der Zwet, Konrad, Egberts, Antoine C G, Fijnvandraat, Karin, Mathôt, Ron, Kruis, Ilmar, Cnossen, Marjon H, Schutgens, Roger, Urbanus, Rolf T, Fischer, Kathelijn
Publicado 2023

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia

por Preijers, Tim, Schütte, Lisette M., Kruip, Marieke J. H. A., Cnossen, Marjon H., Leebeek, Frank W. G., van Hest, Reinier M., Mathôt, Ron A. A.
Publicado 2020

Desmopressin testing in von Willebrand disease: Lowering the burden

por Heijdra, Jessica M., Atiq, Ferdows, Al Arashi, Wala, Kieboom, Quincy, Wuijster, Esmee, Meijer, Karina, Kruip, Marieke J. H. A., Leebeek, Frank W. G., Cnossen, Marjon H.
Publicado 2022

Analytical variation in factor VIII one‐stage and chromogenic assays: Experiences from the ECAT external quality assessment programme

por van Moort, Iris, Meijer, Piet, Priem‐Visser, Debby, van Gammeren, Adriaan J., Péquériaux, Nathalie C. V., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M.
Publicado 2018

The one‐stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non‐severe haemophilia A: Superiority or non‐inferiority?

por Schütte, Lisette M., Hodes, Luca S., van Moort, Iris, Stoof, Sara C. M., Leebeek, Frank W. G., Cnossen, Marjon H., de Maat, Moniek P. M., Kruip, Marieke J. H. A.
Publicado 2020

Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic‐guided dosing of replacement therapy in haemophilia A?

por Goedhart, Tine M.H.J., Bukkems, Laura H., van Moort, Iris, Spence, Colin C., Zwaan, Michel C., de Maat, Moniek P.M., Mathôt, Ron A.A., Cnossen, Marjon H.
Publicado 2022

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable...

por Heijdra, Jessica M, Al Arashi, Wala, de Jager, Nico C B, Cloesmeijer, Michael E, Bukkems, Laura H, Zwaan, Christian M, Leebeek, Frank W G, Mathôt, Ron A A, Cnossen, Marjon H
Publicado 2022

Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort study

por Stokhuijzen, Eva, Rand, Margaret L, Cnossen, Marjon H, Biss, Tina T, James, Paula D, Suijker, Monique H, Peters, Marjolein, van der Lee, Johanna H, Peters, Bram, Meijer, Alexander B, Blanchette, Victor S, Fijnvandraat, Karin
Publicado 2018

Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis

por Houwing, Maite E., Grohssteiner, Rowena L., Dremmen, Marjolein H. G., Atiq, Ferdows, Bramer, Wichor M., de Pagter, Anne P. J., Zwaan, C. Michel, White, Tonya J. H., Vernooij, Meike W., Cnossen, Marjon H.
Publicado 2020